Order Article Reprints

Boianelli A, Nordell P, Earl J, Naylor J, Hornigold D, Jansson Löfmark R, Sundqvist M. Establishing a Relationship between In Vitro Potency in Cell-Based Assays and Clinical Efficacious Concentrations for Approved GLP-1 Receptor Agonists. Pharmaceutics. 2024; 16(10):1310. https://doi.org/10.3390/pharmaceutics16101310

Boianelli, Alessandro, Pär Nordell, Joseph Earl, Jacqueline Naylor, David Hornigold, Rasmus Jansson Löfmark, and Monika Sundqvist. 2024. "Establishing a Relationship between In Vitro Potency in Cell-Based Assays and Clinical Efficacious Concentrations for Approved GLP-1 Receptor Agonists" Pharmaceutics 16, no. 10: 1310. https://doi.org/10.3390/pharmaceutics16101310

Boianelli, A., Nordell, P., Earl, J., Naylor, J., Hornigold, D., Jansson Löfmark, R., & Sundqvist, M. (2024). Establishing a Relationship between In Vitro Potency in Cell-Based Assays and Clinical Efficacious Concentrations for Approved GLP-1 Receptor Agonists. Pharmaceutics, 16(10), 1310. https://doi.org/10.3390/pharmaceutics16101310